These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 35534190)

  • 21. Recent advancements in the use of exosomes as drug delivery systems.
    Bunggulawa EJ; Wang W; Yin T; Wang N; Durkan C; Wang Y; Wang G
    J Nanobiotechnology; 2018 Oct; 16(1):81. PubMed ID: 30326899
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeted Delivery of Exosomes Armed with Anti-Cancer Therapeutics.
    Choi H; Yim H; Park C; Ahn SH; Ahn Y; Lee A; Yang H; Choi C
    Membranes (Basel); 2022 Jan; 12(1):. PubMed ID: 35054611
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Encapsulation and assessment of therapeutic cargo in engineered exosomes: a systematic review.
    Chen Z; Xiong M; Tian J; Song D; Duan S; Zhang L
    J Nanobiotechnology; 2024 Jan; 22(1):18. PubMed ID: 38172932
    [TBL] [Abstract][Full Text] [Related]  

  • 24. State-of-the-art exosome loading and functionalization techniques for enhanced therapeutics: a review.
    Donoso-Quezada J; Ayala-Mar S; González-Valdez J
    Crit Rev Biotechnol; 2020 Sep; 40(6):804-820. PubMed ID: 32605394
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Haematopoietic cell-derived exosomes in cancer development and therapeutics: From basic science to clinical practice.
    Lin WC; Lin YT; Chao HC; Lin YY; Hwang WL
    Clin Transl Med; 2023 Oct; 13(10):e1448. PubMed ID: 37830387
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulation of exosomes as biologic medicines: Regulatory challenges faced in exosome development and manufacturing processes.
    Wang CK; Tsai TH; Lee CH
    Clin Transl Sci; 2024 Aug; 17(8):e13904. PubMed ID: 39115257
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Toward Exosome-Based Therapeutics: Isolation, Heterogeneity, and Fit-for-Purpose Potency.
    Willis GR; Kourembanas S; Mitsialis SA
    Front Cardiovasc Med; 2017; 4():63. PubMed ID: 29062835
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Extracellular vesicles as novel drug delivery systems to target cancer and other diseases: Recent advancements and future perspectives.
    Ramesh D; Bakkannavar S; Bhat VR; Sharan K
    F1000Res; 2023; 12():329. PubMed ID: 37868300
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exosomes as New Generation Vehicles for Drug Delivery: Biomedical Applications and Future Perspectives.
    Rajput A; Varshney A; Bajaj R; Pokharkar V
    Molecules; 2022 Oct; 27(21):. PubMed ID: 36364116
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exploring the clinical transition of engineered exosomes designed for intracellular delivery of therapeutic proteins.
    Kim M; Choi H; Jang DJ; Kim HJ; Sub Y; Gee HY; Choi C
    Stem Cells Transl Med; 2024 Jul; 13(7):637-647. PubMed ID: 38838263
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improvement, scaling-up, and downstream analysis of exosome production.
    Jafari D; Malih S; Eini M; Jafari R; Gholipourmalekabadi M; Sadeghizadeh M; Samadikuchaksaraei A
    Crit Rev Biotechnol; 2020 Dec; 40(8):1098-1112. PubMed ID: 32772758
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interfering with endolysosomal trafficking enhances release of bioactive exosomes.
    Ortega FG; Roefs MT; de Miguel Perez D; Kooijmans SA; de Jong OG; Sluijter JP; Schiffelers RM; Vader P
    Nanomedicine; 2019 Aug; 20():102014. PubMed ID: 31152797
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Manufacturing and characterization of extracellular vesicles from umbilical cord-derived mesenchymal stromal cells for clinical testing.
    Rohde E; Pachler K; Gimona M
    Cytotherapy; 2019 Jun; 21(6):581-592. PubMed ID: 30979664
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Potential Druggability of Mesenchymal Stem/Stromal Cell-derived Exosomes.
    Zhang F; Zhang L; Yu H
    Curr Stem Cell Res Ther; 2024; 19(9):1195-1209. PubMed ID: 38523514
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exosome engineering in cell therapy and drug delivery.
    Sadeghi S; Tehrani FR; Tahmasebi S; Shafiee A; Hashemi SM
    Inflammopharmacology; 2023 Feb; 31(1):145-169. PubMed ID: 36609717
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New advances in exosome-based targeted drug delivery systems.
    Ferreira D; Moreira JN; Rodrigues LR
    Crit Rev Oncol Hematol; 2022 Apr; 172():103628. PubMed ID: 35189326
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Engineering exosomes as refined biological nanoplatforms for drug delivery.
    Luan X; Sansanaphongpricha K; Myers I; Chen H; Yuan H; Sun D
    Acta Pharmacol Sin; 2017 Jun; 38(6):754-763. PubMed ID: 28392567
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Review on Strategies and Technologies for Exosome Isolation and Purification.
    Chen J; Li P; Zhang T; Xu Z; Huang X; Wang R; Du L
    Front Bioeng Biotechnol; 2021; 9():811971. PubMed ID: 35071216
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A review on the use of extracellular vesicles for the delivery of drugs and biological therapeutics.
    Amina SJ; Azam T; Dagher F; Guo B
    Expert Opin Drug Deliv; 2024; 21(1):45-70. PubMed ID: 38226932
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Exosome-Based Drug Delivery: Translation from Bench to Clinic.
    Koh HB; Kim HJ; Kang SW; Yoo TH
    Pharmaceutics; 2023 Jul; 15(8):. PubMed ID: 37631256
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.